Location History:
- MacClesfield, GB (1999 - 2011)
- Cheshire, GB (2006 - 2013)
Company Filing History:
10 out of 1,500 
6 out of 854 
1 out of 107 
Years Active: 1999-2013
Title: The Innovative Contributions of Andrew Stocker
Introduction
Andrew Stocker is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit 11-beta-HSD1. With a total of 17 patents to his name, Stocker has established himself as a key figure in innovation.
Latest Patents
Among his latest patents are the pyrazole derivatives as 11-beta-HSD1 inhibitors. This patent describes a compound of formula (I) and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within. The patent also details their use in the inhibition of 11-beta-HSD1, processes for making them, and pharmaceutical compositions comprising them. Another significant patent involves new crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid. This patent outlines their use in the inhibition of 11-beta-HSD1, processes for making them, and pharmaceutical compositions comprising them.
Career Highlights
Stocker has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Zeneca Limited. His work in these organizations has contributed to advancements in drug development and innovation.
Collaborations
Throughout his career, Stocker has collaborated with notable colleagues such as John Preston and Paul Robert Owen Whittamore. These collaborations have likely enhanced his research and development efforts.
Conclusion
Andrew Stocker’s contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of new therapeutic compounds.